IDEXX Water (Stand C50) is a global provider of water testing solutions that deliver easy, rapid, accurate and cost-effective information on water quality to laboratories and public utilities around the world.
At Healthcare Estates, IDEXX will be showcasing its portfolio of products, including its most recently launched test, Legiolert®, which is an easy to use culture method for the rapid and accurate detection of Legionella pneumophila, the principal causative agent of Legionnaires’ disease.
In June 2019, Legiolert received NF Validation by AFNOR certification. This is a rigorous multi-step process that includes review by a committee of experts from regulatory authorities, public, private and industrial labs, as well as manufacturers. During this process the performance of Legiolert was judged equivalent to the standard method ISO 11731 and to NF T90-431, the culture method used in France, with trial results from 14 laboratories demonstrating strong reproducibility of the method.
Legiolert has also won Water Europe’s coveted 2019 Water Innovation Award in the Water Technology & Infrastructure category. The prize recognizes “innovative breakthrough solutions or technologies” that further Water Europe’s vision of a future-proof model for a European water-smart society.
IDEXX entered the water testing market in 1993 with Colilert®, now one of the most frequently used testing methods for the detection of coliforms and E. coli in water worldwide.
In 2014, IDEXX launched Pseudalert® for the 24-hour detection of Pseudomonas aeruginosa in hospital water systems. Pseudalert, which won the Healthcare Estates IHEEM Product Innovation award in 2014, can be set up with minimal capital expenditure within a facility, to enable in-house testing and monitoring of hospital water systems. Pseudalert gives confirmed results in 24 hours, less than half the time taken by traditional agar culture methods.
For more information visit https://www.idexx.co.uk/en-gb/water/
IDEXX Water UK